Simmunome Inc.
PrivateLast Round
Accelerator
Jun 20, 2025
Total Funding Raised
$1.89M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Simmunome Inc. is a biotechnology company that provides an AI-driven SaaS platform for disease simulations to predict clinical trial outcomes and improve drug discovery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Simmunome Inc. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Simmunome Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jun 20, 2025 | ||||
| Grant | Feb 28, 2025 | ||||
| Pre Seed | Sep 18, 2023 | ||||
| SAFE | Mar 7, 2023 |
Simmunome Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Génome Québec | Grant |
| Sandpiper Ventures | Pre Seed |
| BKR Capital | Pre Seed |
| Consortium Québécois sur la découverte du médicament | Accelerator |
| Accélérateur de création d'entreprises technologiques | Pre Seed |
| Theodorus | Pre Seed |
| Fonds d'investissement Eurêka | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 18, 2026
Monthly visitors increased 115% MoM.
Simmunome Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Simmunome Inc.'s valuation, stock price, and market status.